Yes I think they do interim analysis, which would be assessed by the DSMB overseeing the trial to ensure there were no safety concerns. For the company the data is still blinded though so the only comparison they have is overall response rates compared to the phase 2 trial. A previous update said that so far response rates were similar.
Yes I think they do interim analysis, which would be assessed by...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $437.4M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.5¢ | $162.9K | 245.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 759 | 70.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.5¢ | 3441 | 3 |
View Market Depth
| Last trade - 15.59pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
66.0¢ |
Change
0.000 ( 0.89 %) |
||||
| Open | High | Low | Volume | ||
| 66.5¢ | 67.0¢ | 65.8¢ | 36570 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| OPT (ASX) Chart |